U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C7H5N3O2
Molecular Weight 163.1335
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 7-NITROINDAZOLE

SMILES

[O-][N+](=O)C1=CC=CC2=C1NN=C2

InChI

InChIKey=PQCAUHUKTBHUSA-UHFFFAOYSA-N
InChI=1S/C7H5N3O2/c11-10(12)6-3-1-2-5-4-8-9-7(5)6/h1-4H,(H,8,9)

HIDE SMILES / InChI

Molecular Formula C7H5N3O2
Molecular Weight 163.1335
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

7-Nitroindazole (aka 7-NI) is an experimental small molecule that acts as a selective inhibitor of neuronal nitric oxide synthase, which normally converts arginine to citrulline and nitric oxide (NO) in neuronal tissues. It has been investigated for potential use as an anti-nociceptive compound and as a means of mitigating neurodegenerative damage.

CNS Activity

Curator's Comment: referenced study was conducted in mice

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: P29475
Gene ID: 4842.0
Gene Symbol: NOS1
Target Organism: Homo sapiens (Human)
0.9 µM [IC50]
Target ID: P29474|||Q14434
Gene ID: 4846.0
Gene Symbol: NOS3
Target Organism: Homo sapiens (Human)
3.67 null [pEC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Effect of cyclooxygenase and NO synthase inhibitors on antinociceptive action of acetaminophen.
2002-05-07
N(G)-nitro-L-arginine and its methyl ester inhibit brain synthesis of kynurenic acid possibly via nitric oxide-independent mechanism.
2002-05-03
Differential contributions of nitric oxide synthase isoforms at hippocampal formation to negative feedback regulation of penile erection in the rat.
2002-05
Facilitatory role of NO in neural norepinephrine release in the rat kidney.
2002-05
NO synthase inhibitors attenuate locus coeruleus catecholamine metabolism and behavior induced by morphine withdrawal.
2002-04-16
Inhibition of neuronal nitric oxide synthase increases adrenalectomy-induced granule cell death in the rat dentate gyrus.
2002-04-12
Protection of methylmercury effects on the in vivo dopamine release by NMDA receptor antagonists and nitric oxide synthase inhibitors.
2002-04
Motor effects of acute and chronic inhibition of nitric oxide synthesis in mice.
2002-04
Involvement of neuronal nitric oxide synthase in restraint stress-induced fever in rats.
2002-03-14
Selective inhibition of neuronal nitric oxide synthesis reduces hyperactivity and increases non-selective attention in the Naples High-Excitability rat.
2002-03-10
Nitric oxide modulation of neurally induced proximal tubular fluid reabsorption in the rat.
2002-03-01
Alterations of the nitric oxide pathway in cerebral arteries from spontaneously hypertensive rats.
2002-03
Endothelin-A receptors and NO mediate decrease in arterial pressure during recovery from restraint.
2002-03
Abnormal expression of neuronal nitric oxide synthase triggers limbic seizures and hippocampal damage in rat.
2002-02-22
Mutant mice deficient in NOS-1 exhibit attenuated long-term facilitation and short-term potentiation in breathing.
2002-02-15
Mechanisms of glutamate release in the rat spinal cord slices during metabolic inhibition.
2002-02
Mechanism by which superoxide potentiates tubuloglomerular feedback.
2002-02
Neuronal nitric oxide synthase inhibition decreases cocaine self-administration behavior in rats.
2002-02
The effects of the nitric oxide synthase inhibitors on the behaviour of small-platform-stressed mice in the plus-maze test.
2002-02
Compensatory role of NO in cerebral circulation of piglets chronically treated with indomethacin.
2002-02
Neuronal NOS-dependent dilation to flow in coronary arteries of male eNOS-KO mice.
2002-02
The effect of 7-nitroindazole on the acquisition and expression of D-methamphetamine-induced place preference in rats.
2002-01-25
Effects of intracerebroventricular administration of 7-nitroindazole on tolerance to ethanol.
2002-01-15
Multiple mechanisms of vascular smooth muscle relaxation by the activation of proteinase-activated receptor 2 in mouse mesenteric arterioles.
2002-01
Neuroprotective MK801 is associated with nitric oxide synthase during hypoxia/reoxygenation in rat cortical cell cultures.
2002
Inhibition of different types of nitric oxide synthase: effect on thermoregulation in the rat exposed to high ambient temperature.
2001-12-04
Effects of long-term inhibition of neuronal nitric oxide synthase on blood pressure and renin release.
2001-12
NO mediates ginsenoside Rg1-induced long-term potentiation in anesthetized rats.
2001-12
Pharmacokinetics and pharmacodynamics of 7-nitroindazole, a selective nitric oxide synthase inhibitor, in the rat hippocampus.
2001-11
Role of spinal NMDA receptors, protein kinase C and nitric oxide synthase in the hyperalgesia induced by magnesium deficiency in rats.
2001-11
Role of neuronal nitric oxide synthase in the macula densa.
2001-11
The effects of nitric oxide synthase inhibitors on the sedative effect of clonidine.
2001-11
Nitric oxide modulates sympathoexcitatory cardiac-cardiovascular reflexes elicited by bradykinin.
2001-11
Role of neuronal nitric oxide synthase in mediating renal hemodynamic changes during pregnancy.
2001-11
Delayed induction of p38 MAPKs in reactive astrocytes in the brain of mice after KA-induced seizure.
2001-10-19
Nitric oxide inhibition of cAMP synthesis in parotid acini: regulation of type 5/6 adenylyl cyclase.
2001-10
Different effects between 7-nitroindazole and L-NAME on cerebral hemodynamics and hippocampal lesions during kainic acid-induced seizures in newborn rabbits.
2001-10
Nitric oxide synthase in spinal cord central sensitization following intradermal injection of capsaicin.
2001-10
Nitric oxide synthase and cGMP-mediated stimulation of renin secretion.
2001-10
Nitric oxide is required for the induction and heterosynaptic spread of long-term potentiation in rat cerebellar slices.
2001-09-15
The nNOS/cGMP signal transducing system is involved in the cardiovascular responses induced by activation of NMDA receptors in the rostral ventrolateral medulla of cats.
2001-09-14
Delayed induction of alpha B-crystallin in activated glia cells of hippocampus in kainic acid-treated mouse brain.
2001-09-01
Inhibition of nitric oxide production during global ischemia ameliorates ischemic damage of pyramidal neurons in the hippocampus.
2001-09
Neuronal nitric oxide synthase (NOS) regulates leukocyte-endothelial cell interactions in endothelial NOS deficient mice.
2001-09
Inhibition of neuronal nitric oxide synthase ameliorates renal hyperfiltration in streptozotocin-induced diabetic rat.
2001-09
Interactions between nitric oxide and renal nerves in the excretion of a saline load in obese Zucker rats.
2001-09
Nitric oxide enhances MPP(+) inhibition of complex I.
2001-08-24
Comparison of N2O- and chlordiazepoxide-induced behaviors in the light/dark exploration test.
2001-04
Role of astrocytes in trimethyltin neurotoxicity.
2001
Nitric oxide- and oxygen-derived free radical generation from control and lipopolysaccharide-treated rat polymorphonuclear leukocyte.
2001
Patents

Sample Use Guides

7-Nitroindazole was administered to mice by intraperitoneal injection in a dose range of 10 - 50 mg/kg. 7-Nitroindazole demonstrated anti-nociceptive effects in the late phase of the formalin-induced hind-paw licking and acetic acid-induced abdominal constriction assays; the ED50 for each assay was 27.5 and 22.5 mg/kg respectively. Maximum antinociceptive activity and NOS inhibition were detected 18-30 min following i.p. administration.
Route of Administration: Intraperitoneal
In Vitro Use Guide
Rabbit aortic rings (with and without endothelium) were mounted for isometric tensile recording in an organ bath containing Krebs solution at 37 deg-C in an atmosphere of 5% CO2. The tissue was placed under an initial tension of 2 g and left to equilibrate for 30 - 45 minutes. Aortic rings were then precontracted with 0.2 micro-M phenylephrine. Once stable contractions were observed, cumulative concentration-effect curves were determined for 7-Nitroindazole (1 micro-M to 1 mM). Concentration-effect curves to 7-Nitroindazole were also determined in rabbit aorta after incubation with the nitric oxide synthase inhibitor L-N^G-nitro arginine p-nitroanilide (50 micro-M) for 60 minutes. The failure of acetylcholine (2 micro-M) to induce relaxation in rabbit aorta was taken as an indication of the absence of a functional endothelium. 7-Nitroindazole caused concentration-dependent relaxations in rabbit aorta with a -log EC50 of 3.67. The relaxant response to 7-Nitroindazole was not significantly different in aortic rings with or without a functional endothelium, or after pretreatment with L-N^G-nitro arginine p-nitroanilide.
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:58:23 GMT 2025
Edited
by admin
on Mon Mar 31 18:58:23 GMT 2025
Record UNII
UX0N37CMVH
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NSC-72843
Preferred Name English
7-NITROINDAZOLE
Systematic Name English
NITROINDAZOLE, 7-
Systematic Name English
Code System Code Type Description
SMS_ID
300000053103
Created by admin on Mon Mar 31 18:58:23 GMT 2025 , Edited by admin on Mon Mar 31 18:58:23 GMT 2025
PRIMARY
PUBCHEM
1893
Created by admin on Mon Mar 31 18:58:23 GMT 2025 , Edited by admin on Mon Mar 31 18:58:23 GMT 2025
PRIMARY
CAS
2942-42-9
Created by admin on Mon Mar 31 18:58:23 GMT 2025 , Edited by admin on Mon Mar 31 18:58:23 GMT 2025
PRIMARY
DRUG BANK
DB02207
Created by admin on Mon Mar 31 18:58:23 GMT 2025 , Edited by admin on Mon Mar 31 18:58:23 GMT 2025
PRIMARY
NSC
72843
Created by admin on Mon Mar 31 18:58:23 GMT 2025 , Edited by admin on Mon Mar 31 18:58:23 GMT 2025
PRIMARY
FDA UNII
UX0N37CMVH
Created by admin on Mon Mar 31 18:58:23 GMT 2025 , Edited by admin on Mon Mar 31 18:58:23 GMT 2025
PRIMARY
WIKIPEDIA
7-Nitroindazole
Created by admin on Mon Mar 31 18:58:23 GMT 2025 , Edited by admin on Mon Mar 31 18:58:23 GMT 2025
PRIMARY
EPA CompTox
DTXSID30183638
Created by admin on Mon Mar 31 18:58:23 GMT 2025 , Edited by admin on Mon Mar 31 18:58:23 GMT 2025
PRIMARY
ECHA (EC/EINECS)
220-934-4
Created by admin on Mon Mar 31 18:58:23 GMT 2025 , Edited by admin on Mon Mar 31 18:58:23 GMT 2025
PRIMARY
Related Record Type Details
ACTIVE MOIETY